Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-09-010809
Filing Date
2009-02-19
Accepted
2009-02-19 17:22:12
Documents
1
Period of Report
2009-02-17

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3797
  Complete submission text file 0001104659-09-010809.txt   5623
Mailing Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039
Business Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 9739943999
COLUMBIA LABORATORIES INC (Issuer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address TC MANAGEMENT 237 PARK AVE STE 800 NEW YORK NY 10017 2128083444
CAMPBELL ANTHONY R (Reporting) CIK: 0001073308 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-10352 | Film No.: 09622454